Back to results
US 2024/0229037 A1Published application
SIRNA TARGETING 17Beta-HYDROXYSTEROID DEHYDROGENASE TYPE 13 AND SIRNA CONJUGATE
AssigneeTuojie Biotech (Shanghai) Co., Ltd.
InventorsJinyu HUANG, Yanfen HUANG, Min LUO, Fang ZHANG
Life of this patent
Estimating the term…
Abstract
An siRNA targeting 170-hydroxysteroid dehydrogenase type 13 and a siRNA conjugate. Also disclosed are a pharmaceutical composition, cell or kit containing the siRNA, and a method for using the siRNA for the treatment and/or prevention of subjects suffering from HSD17B13-related disorders (such as chronic fibroinflammatory liver disease).
Claims20
An siRNA, comprising a sense strand and an antisense strand forming a double-stranded region, wherein:
- the sense strand comprises at least 15 contiguous nucleotides and differs from any one of nucleotide sequences of SEQ ID NOs:
- 24, 4, 6, 11, 3, 5, 7, 8, 9, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, and 23 by no more than 3 nucleotides;
- the antisense strand comprises at least 15 contiguous nucleotides and differs from any one of nucleotide sequences of SEQ ID NOs:
- 46, 26, 28, 33, 25, 27, 29, 30, 31, 32, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, and 45 by no more than 3 nucleotides.
1 more element
(canceled)
Dependencies are inferred from the claim text.